Проблемы полипрагмазии и лекарственного взаимодействия в терапии неосложненного острого риносинусита

Закрыть метаданные

В настоящей публикации рассматриваются полипрагмазия и лекарственное взаимодействие в терапии неосложненного острого риносинусита у детей и взрослых. Лечение риносинусита в амбулаторных условиях у мультиморбидных пациентов может сопровождаться множественными назначениями, что повышает риск межлекарственных взаимодействий. В статье отражены наиболее значимые нецелесообразные комбинации как лекарственных средств, так и биологически активных добавок, растительных препаратов. Рассмотрены преимущества применения средств с доказанной эффективностью, в частности интраназальных глюкокортикостероидов.

Ключевые слова:

полипрагмазия

полифармация

риносинусит

лекарственное взаимодействие

рациональная терапия

интраназальные лекарственные средства

безопасность фармакотерапии

Авторы:

Зырянов С.К.

ФГАОУ ВО «Российский университет дружбы народов им. Патриса Лумумбы» Минобрнауки России;
ГБУЗ города Москвы «Городская клиническая больница №24 Департамента здравоохранения города Москвы»

ORCID: 0000-0002-6348-6867

Строк А.Б.

ФГАОУ ВО «Российский университет дружбы народов им. Патриса Лумумбы» Минобрнауки России;
ОСП Российская детская клиническая больница ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России

ORCID: 0000-0001-5769-0450

Дата поступления:

13.02.2024

Дата принятия в печать:

13.05.2024

Список литературы:

Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, Phillips B, Lelgemann M, Lethaby A, Bousquet J, Guyatt GH, Schünemann HJ; GRADE Working Group. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64(5):669-677. https://doi.org/10.1111/j.1398-9995.2009.01973.x
Neumark T, Brudin L, Engstrom S, Molstad S. Trends in number of consultations and antibiotic prescriptions for respiratory tract infections between 1999 and 2005 in primary healthcare in Kalmar County, Southern Sweden. Scandinavian Journal of Primary Health Care. 2009;27(1):18-24. https://doi.org/10.1080/02813430802610784
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatrics. 2017;17(1):230. https://doi.org/10.1186/s12877-017-0621-2
Duerden M, Avery T, Payne R. Polypharmacy and Medicines Optimisation: Making it Safe and Sound. The King’s Fund; 2013. https://www.kingsfund.org.uk/publications/polypharmacy-and-medicines-optimisation
Varghese D, Ishida C, Haseer Koya H. Polypharmacy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; August 28, 2023. PMID: 30422548.
Костылева М.Н., Строк А.Б., Постников С.С., Грацианская А.Н., Ермилин А.Е. Фармакотерапия в многопрофильном педиатрическом стационаре: полипрагмазия и риск лекарственных взаимодействий на примере клинического случая. Безопасность и риск фармакотерапии. 2022;10(3):302-314. https://doi.org/10.30895/2312-7821-2022-10-3-302-314
WHO Medication without Harm: WHO Global Patient Safety Challenge. Accessed May 13, 2024. https://www.who.int/publications/i/item/WHO-HIS-SDS-2017.6
Daunt R, Curtin D, O’Mahony D. Polypharmacy stewardship: A novel approach to tackle a major public health crisis. The Lancet. Healthy Longevity. 2023;4(5):e228-e235. https://doi.org/10.1016/S2666-7568(23)00036-3
Wilson JF. In the clinic. Acute sinusitis [published correction appears in Ann Intern Med. 2010;153(12):851] [published correction appears in Ann Intern Med. 2010;153(9):620]. Annals of Internal Medicine. 2010;153(5):ITC31-ITC316. https://doi.org/10.7326/0003-4819-153-5-201009070-01003
DeBoer DL, Kwon E. Acute Sinusitis. 2023 Aug 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang de Y, Wormald PJ. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinology Supplement. 2012;23:3-298.
Крюков А.И., Туровский А.Б., Колбанова И.Г., Лучшева Ю.В., Мусаев К.М., Карасов А.Б. Проблема лечения синусита на фоне аллергического ринита. Медицинский совет. 2019;8:110-114. https://doi.org/10.21518/2079-701X-2019-8-110-114
DeMuri GP, Gern JE, Moyer SC, Lindstrom MJ, Lynch SV, Wald ER. Clinical Features, Virus Identification, and Sinusitis as a Complication of Upper Respiratory Tract Illness in Children Ages 4-7 Years. Journal of Pediatrics. 2016;171:133-139.e1. https://doi.org/10.1016/j.jpeds.2015.12.034
Tan KS, Yan Y, Ong HH, Chow VTK, Shi L, Wang D-Y. Impact of Respiratory Virus Infections in Exacerbation of Acute and Chronic Rhinosinusitis. Current Allergy and Asthma Reports. 2017;17:24. PMID: 28389843; PMCID: PMC7088794. https://doi.org/10.1007/s11882-017-0693-2
Крюков А.И., Кунельская Н.Л., Гуров А.В. и др. Фармакотерапия гнойно-воспалительной патологии ЛОР-органов. Методические рекомендации Департамента здравоохранения г. Москвы. М.: Из-во ДЗ г. Москвы; 2018.
Острый риносинусит: клинические рекомендации. Под ред. Лопатина А.С. Российское общество ринологов. М. 2017.
Aring AM, Chan MM. Current concepts in adult acute rhinosinusitis. American Family Physician. 2016;94:97-105.
Вишнева Е.А., Намазова-Баранова Л.С., Селимзянова Л.Р., Алексеева А.А. Риниты у детей: современные аспекты диагностики и лечения. Педиатрическая фармакология. 2016;13(2): 149-157. https://doi.org/10.15690/pf.v13i2.1556
Носуля Е.В. Антибиотики в комплексной терапии бактериального риносинусита: возможности и ограничения. Российская ринология. 2014;22(3):36-40.
Чучалин А.Г., ред. Респираторная медицина. Руководство. В 3 т. Т. 1. М.: ГЭОТАР-Медиа; 2017.
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, Toppila-Salmi S, Bernal-Sprekelsen M, Mullol J, Alobid I, Terezinha Anselmo-Lima W, Bachert C, Baroody F, von Buchwald C, Cervin A, Cohen N, Constantinidis J, De Gabory L, Desrosiers M, Diamant Z, Douglas RG, Gevaert PH, Hafner A, Harvey RJ, Joos GF, Kalogjera L, Knill A, Kocks JH, Landis BN, Limpens J, Lebeer S, Lourenco O, Meco C, Matricardi PM, O’Mahony L, Philpott CM, Ryan D, Schlosser R, Senior B, Smith TL, Teeling T, Tomazic PV, Wang DY, Wang D, Zhang L, Agius AM, Ahlstrom-Emanuelsson C, Alabri R, Albu S, Alhabash S, Aleksic A, Aloulah M, Al-Qudah M, Alsaleh S, Baban MA, Baudoin T, Balvers T, Battaglia P, Bedoya JD, Beule A, Bofares KM, Braverman I, Brozek-Madry E, Richard B, Callejas C, Carrie S, Caulley L, Chussi D, de Corso E, Coste A, El Hadi U, Elfarouk A, Eloy PH, Farrokhi S, Felisati G, Ferrari MD, Fishchuk R, Grayson W, Goncalves PM, Grdinic B, Grgic V, Hamizan AW, Heinichen JV, Husain S, Ping TI, Ivaska J, Jakimovska F, Jovancevic L, Kakande E, Kamel R, Karpischenko S, Kariyawasam HH, Kawauchi H, Kjeldsen A, Klimek L, Krzeski A, Kopacheva Barsova G, Kim SW, Lal D, Letort JJ, Lopatin A, Mahdjoubi A, Mesbahi A, Netkovski J, Nyenbue Tshipukane D, Obando-Valverde A, Okano M, Onerci M, Ong YK, Orlandi R, Otori N, Ouennoughy K, Ozkan M, Peric A, Plzak J, Prokopakis E, Prepageran N, Psaltis A, Pugin B, Raftopulos M, Rombaux P, Riechelmann H, Sahtout S, Sarafoleanu CC, Searyoh K, Rhee CS, Shi J, Shkoukani M, Shukuryan AK, Sicak M, Smyth D, Sindvongs K, Soklic Kosak T, Stjarne P, Sutikno B, Steinsvag S, Tantilipikorn P, Thanaviratananich S, Tran T, Urbancic J, Valiulius A, Vasquez de Aparicio C, Vicheva D, Virkkula PM, Vicente G, Voegels R, Wagenmann MM, Wardani RS, Welge-Lussen A, Witterick I, Wright E, Zabolotniy D, Zsolt B, Zwetsloot CP. EPOS 2020: European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl 29):53-95. https://doi.org/10.4193/Rhin20.600
Лопатин А.С. Острый риносинусит в EPOS 2020 и обновленных клинических рекомендациях Российского общества ринологов. Фармакология и фармакотерапия. 2022;(Спецвыпуск):30-36. https://doi.org/10.46393/27132129_2022_S_30
Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU, Poetker DM, Soler Z, Welch KC, Wise SK, Adappa N, Alt JA, Anselmo-Lima WT, Bachert C, Baroody FM, Batra PS, Bernal-Sprekelsen M, Beswick D, Bhattacharyya N, Chandra RK, Chang EH, Chiu A, Chowdhury N, Citardi MJ, Cohen NA, Conley DB, DelGaudio J, Desrosiers M, Douglas R, Eloy JA, Fokkens WJ, Gray ST, Gudis DA, Hamilos DL, Han JK, Harvey R, Hellings P, Holbrook EH, Hopkins C, Hwang P, Javer AR, Jiang RS, Kennedy D, Kern R, Laidlaw T, Lal D, Lane A, Lee HM, Lee JT, Levy JM, Lin SY, Lund V, McMains KC, Metson R, Mullol J, Naclerio R, Oakley G, Otori N, Palmer JN, Parikh SR, Passali D, Patel Z, Peters A, Philpott C, Psaltis AJ, Ramakrishnan VR, Ramanathan M Jr, Roh HJ, Rudmik L, Sacks R, Schlosser RJ, Sedaghat AR, Senior BA, Sindwani R, Smith K, Snidvongs K, Stewart M, Suh JD, Tan BK, Turner JH, van Drunen CM, Voegels R, Wang Y, Woodworth BA, Wormald PJ, Wright ED, Yan C, Zhang L, Zhou B. International consensus statement on allergy and rhinology: rhinosinusitis 2021. International Forum of Allergy and Rhinology. 2021;11(3):213-739. https://doi.org/10.1002/alr.22741
Острый синусит. Клинические рекомендации. 2021. Ссылка активна на 13.05.24. https://cr.minzdrav.gov.ru/schema/313_2
Forchhammer J. The in vitro activity of framycetin. Spectrum, sensitivity test and cross resistance. Acta Pathologica et Microbiologica Scandinavica. 1964;60:549-556. https://doi.org/10.1111/apm.1964.60.4.549
Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL, Forrest A, Giacobbe DR, Viscoli C, Giamarellou H, Karaiskos I, Kaye D, Mouton JW, Tam VH, Thamlikitkul V, Wunderink RG, Li J, Nation RL, Kaye KS. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019;39(1):10-39. PMID: 30710469; PMCID: PMC7437259. https://doi.org/10.1002/phar.2209
Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, Lanza DC, Marple BF, Osguthorpe JD, Stankiewicz JA, Anon J, Denneny J, Emanuel I, Levine H. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Archives of Otolaryngology — Head and Neck Surgery. 2003;129(3 Suppl):S1-S32. https://doi.org/10.1016/s0194-5998(03)01397-4
Vining EM. Evolution of medical management of chronic rhinosinusitis. The Annals of Otology, Rhinology, and Laryngology. 2006;196:54-60. https://doi.org/10.1177/00034894061150s909
Woodhouse BM, Cleveland KW. Nebulized antibiotics for the treatment of refractory bacterial chronic rhinosinusitis. Annals of Pharmacotherapy. 2011;45(6):798-802. https://doi.org/10.1345/aph.1P723
Landini G, Di Maggio T, Sergio F, Docquier JD, Rossolini GM, Pallecchi L. Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens. Antimicrobial Agents and Chemotherapy. 2016;60(12): 7513-7517. https://doi.org/10.1128/AAC.01334-16
Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology. 1977;5(1):58-61. https://doi.org/10.1128/jcm.5.1.58-61.1977
Аллергический ринит. Клинические рекомендации. 2020. Ссылка активна на 13.05.24. https://cr.minzdrav.gov.ru/recomend/261_1
Инструкция по медицинскому применению препарата Изофра. Ссылка активна на 13.05.24. https://grls.rosminzdrav.ru
Lemiengre MB, van Driel ML, Merenstein D, Liira H, Mäkelä M, De Sutter AI. Antibiotics for acute rhinosinusitis in adults. The Cochrane Database of Systematic Reviews. 2018;9(9):CD006089. PMID: 23076918. https://doi.org/10.1002/14651858.CD006089.pub5
Passali D, Spinosi MC, Crisanti A, Bellussi LM. Mometasone furoate nasal spray: A systematic review. Multidisciplinary Respiratory Medicine. 2016;11:18. https://doi.org/10.1186/s40248-016-0054-3
Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinology Supplement. 2007;20:1-136.
Young Jang T, Hyo Kim Y. Recent updates on the systemic and local safety of intranasal steroids. Current Drug Metabolism. 2016; 17(10):992-996. https://doi.org/10.2174/1389200218666161123123516
Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. The Journal of Allergy and Clinical Immunology. 2005;116(6):1289-1295. https://doi.org/10.1016/j.jaci.2005.08.044
Nayak AS, Settipane GA, Pedinoff A, Charous BL, Meltzer EO, Busse WW, Zinreich SJ, Lorber RR, Rikken G, Danzig MR; Nasonex Sinusitis Group. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Annals of Allergy, Asthma and Immunology. 2002;89(3):271-278. https://doi.org/10.1016/S1081-1206(10)61954-0
Dolor RJ, Witsell DL, Hellkamp AS, Williams JW Jr, Califf RM, Simel DL; Ceftin and Flonase for Sinusitis (CAFFS) Investigators. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: A randomized controlled trial. JAMA. 2001;286(24):3097-3105. https://doi.org/10.1001/jama.286.24.3097
Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. The Cochrane Database of Systematic Reviews. 2013; 2013(12):CD005149. https://doi.org/10.1002/14651858.CD005149.pub4
Zhang N, Truong-Tran QA, Tancowny B, Harris KE, Schleimer RP. Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins. Journal of Immunology. 2007;179(1):578-589. https://doi.org/10.4049/jimmunol.179.1.578
Samoliński B, Nowicka A, Wojas O, Lipiec A, Krzych-Fałta E, Tomaszewska A. Intranasal glucocorticosteroids — not only in allergic rhinitis In the 40th anniversary of intranasal glucocorticosteroids’ introduction. The Polish Otolaryngology. 2014;68(2):51-64. https://doi.org/10.1016/j.otpol.2013.12.003
Sharpe SA, Sandweiss V, Tuazon J, Giordano M, Witchey-Lakshmanan L, Hart J, Sequeira J. Comparison of the flow properties of aqueous suspension corticosteroid nasal sprays under differing sampling conditions. Drug Development and Industrial Pharmacy. 2003;29(9):1005-1012. https://doi.org/10.1081/ddc-120025457
Minshall E, Ghaffar O, Cameron L, O’Brien F, Quinn H, Rowe-Jones J, Davies RJ, Prior A, Lund VJ, Mackay IS, Nolop K, Lutsky B, Durham SR, Hamid Q. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngology — Head and Neck Surgery. 1998;118(5):648-654. https://doi.org/10.1177/019459989811800514
Schenkel EJ, Skoner DP, Bronsky EA, Miller SD, Pearlman DS, Rooklin A, Rosen JP, Ruff ME, Vandewalker ML, Wanderer A, Damaraju CV, Nolop KB, Mesarina-Wicki B. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics. 2000;105(2):E22. https://doi.org/10.1542/peds.105.2.e22
Polat C, Uysal EB, Yüce S, Uysal IO, Koç S. The effect of topical mometasone furoate nasal spray on carriage of Staphylococcus aureus. KBB = Journal of Ear, Nose, and Throat. 2014;24(1):1-5. https://doi.org/10.5606/kbbihtisas.2014.70120
Seymour N, Robinson M, Richardson D, Mohammed H, Williams D, McGilligan JA. Prescribing intranasal steroids in HIV-positive patients: systematic review of the literature. The Journal of Laryngology and Otology. 2021;135(9):755-758. https://doi.org/10.1017/S0022215121001791
Friese K-H, Zabalotnyi DI. [Homeopathy in acute rhinosinusitis: A double-blind, placebo controlled study shows the efficiency and tolerability of a homeopathic combination remedy]. HNO. 2007;55(4):271-277. (In German). https://doi.org/10.1007/s00106-006-1480-x
Zabolotnyi DI, Kneis KC, Richardson A, Rettenberger R, Heger M, Kaszkin-Bettag M, Heger PW. Efficacy of a complex homeopathic medication (Sinfrontal) in patients with acute maxillary sinusitis: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial. Explore. 2007;3(2):98-109. https://doi.org/10.1016/j.explore.2006.12.007
Gabrielian ES, Shukarian AK, Goukasova GI, Chandanian GL, Panossian AG, Wikman G, Wagner H. A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine. 2002;9(7):589-597. https://doi.org/10.1078/094471102321616391
Ponikau JU, Hamilos DL, Barreto A, Cecil J, Jones SW, Manthei SE, Collins J. An exploratory trial of Cyclamen europaeum extract for acute rhinosinusitis. Laryngoscope. 2012;122(9):1887-1892. https://doi.org/10.1002/lary.23366
Federspil P, Wulkow R, Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis — results of a doubleblind, randomized multicenter study compared with placebo. Laryngorhinootologie. 1997;76(1):23-27. https://doi.org/10.1055/s-2007-997381
Neubauer N, März RW. Placebo-controlled, randomized double-blind clinical trial with Sinupret sugar coated tablets on the basis EPOS 2020 112 of a therapy with antibiotics and decongestant nasal drops in acute sinusitis. Phytomedicine. 1994;1:177-181.
Pfaar O, Mullol J, Anders C, Hormann K, Klimek L. Cyclamen europaeum nasal spray, a novel phytotherapeutic product for the management of acute rhinosinusitis: A randomized double-blind, placebo-controlled trial. Rhinology. 2012;50:37-44.
Bachert C, Schapowal A, Funk P, Kieser M. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: A randomized, double-blind, placebocontrolled trial. Rhinology. 2009;47:51-58.
Fasinu PS, Bouic PJ, Rosenkranz B. An overview of the evidence and mechanisms of herb-drug interactions. Frontiers in Pharmacology. 2012;3:69. https://doi.org/10.3389/fphar.2012.00069
Girard L, Vohra S. Ethics of Using Herbal Medicine as Primary or Adjunct Treatment and Issues of Drug-Herb Interaction. In: Benzie IFF, Wachtel-Galor S, eds. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 21. Accessed May 13, 2024. https://www.ncbi.nlm.nih.gov/books/NBK92754
Williams CT. Herbal Supplements: Precautions and Safe Use. Nursing Clinics of North America. 2021;56(1):1-21. https://doi.org/10.1016/j.cnur.2020.10.001
Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clinical Pharmacology and Therapeutics. 2004;75(1):89-100. https://doi.org/10.1016/j.clpt.2003.09.013
Bossaer JB, Odle BL. Probable etoposide interaction with Echinacea. Journal of Dietary Supplements. 2012;9(2):90-95. https://doi.org/10.3109/19390211.2012.682643
Ших ЕВ, Булаев ВМ, Демидова ОА, Сокова ЕА. Взаимодействие биологически активных веществ лекарственных растительных препаратов с другими фармакотерапевтическими средствами. Ведомости Научного центра экспертизы средств медицинского применения. 2016;(4):48-52.
Демидова О.А., Архипов В.В., Журавлева М.В., Александрова Т.В., Александров А.А. Безопасность лекарственных растительных препаратов: клинико-фармакологические аспекты. Безопасность и риск фармакотерапии. 2020;8(4):165-177. https://doi.org/10.30895/2312-7821-2020-8-4-165-177
Di Lorenzo C, Ceschi A, Kupferschmidt H, Lüde S, De Souza Nascimento E, Dos Santos A, Colombo F, Frigerio G, Nørby K, Plumb J, Finglas P, Restani P. Adverse effects of plant food supplements and botanical preparations: A systematic review with critical evalution of causality. British Journal of Clinical Pharmacology. 2015;79(4):578-592. https://doi.org/10.1111/bcp.12519
Государственный реестр лекарственных средств. Ссылка активна на 13.05.24. https://grls.minzdrav.gov.ru
Инструкция по медицинскому применению препарата Полидекса с фенилэфрином. Ссылка активна на 13.05.24. https://grls.rosminzdrav.ru

Закрыть метаданные